Skip to content
10-Q

Quarterly Report

CHINA-BIOTICS, INC

0001144204-13-008898

← back to feed
Filed
Feb 14, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Feb 13, 2013 22.15M sh
Shares Diluted Q3 2012 · Dec 31, 2012 22.15M sh
Shares Diluted Q3 2012 · Dec 31, 2012 22.15M sh
Operating Cash Flow Q3 2012 · Dec 31, 2012 $21.46M
Short Term Debt Q3 2012 · Dec 31, 2012 $15.87M
Short Term Debt Q3 2012 · Mar 31, 2012 $3.17M
Cash And Equivalents Q3 2012 · Dec 31, 2012 $68.45M
Cash And Equivalents Q3 2012 · Mar 31, 2012 $70.09M
Stockholders Equity Q3 2012 · Dec 31, 2012 $220.69M
Stockholders Equity Q3 2012 · Mar 31, 2012 $202.43M
Current Liabilities Q3 2012 · Dec 31, 2012 $57.3M
Current Liabilities Q3 2012 · Mar 31, 2012 $49.78M
Total Liabilities Q3 2012 · Dec 31, 2012 $57.3M
Total Liabilities Q3 2012 · Mar 31, 2012 $54.53M
Current Assets Q3 2012 · Dec 31, 2012 $108.4M
Current Assets Q3 2012 · Mar 31, 2012 $106.99M
Total Assets Q3 2012 · Dec 31, 2012 $277.98M
Total Assets Q3 2012 · Mar 31, 2012 $256.96M
Eps Diluted Q3 2012 · Dec 31, 2012 $0.40
Eps Diluted Q3 2012 · Dec 31, 2012 $0.75
Eps Basic Q3 2012 · Dec 31, 2012 $0.40
Eps Basic Q3 2012 · Dec 31, 2012 $0.75
Sga Expense Q3 2012 · Dec 31, 2012 $3.39M
Sga Expense Q3 2012 · Dec 31, 2012 $10.99M
Net Income Q3 2012 · Dec 31, 2012 $8.93M
Net Income Q3 2012 · Dec 31, 2012 $16.71M
Operating Income Q3 2012 · Dec 31, 2012 $9.83M
Operating Income Q3 2012 · Dec 31, 2012 $18.14M
Gross Profit Q3 2012 · Dec 31, 2012 $15.86M
Gross Profit Q3 2012 · Dec 31, 2012 $38.38M
Cost Of Revenue Q3 2012 · Dec 31, 2012 $8.82M
Cost Of Revenue Q3 2012 · Dec 31, 2012 $23.83M